Written by

BioLabs Philadelphia Opens Graduate Lab Coworking Space in Center City

International developer and operator of life science coworking and shared lab space BioInnovation Labs (BioLabs) recently announced it would be opening a state-of-the-art graduate facility at The Curtis in Center City West, Philadelphia.

Located in the highly desirable Washington Square neighborhood, the property’s office component boasts first-class wet labs and collaborative workspaces, alongside luxury residences and fine dining. The landmark former publishing house rises 12 stories and incorporates roughly 762,000 square feet of Center City Philadelphia office space, along with 50,000 square feet of retail space and about 100,000 square feet of residential property.

“We have a strong commitment to the Philadelphia innovation ecosystem, and we are excited to build upon our local team’s many years of experience in supporting the sophisticated biotech companies that call Philly home,” said President and CEO of BioLabs, Johannes Fruehauf, PhD, MD. “We’re embracing our new home at The Curtis and look forward to continuing to share our expertise with the local community. Additionally, we thank our industry sponsors for supporting our residents and look forward to working with them to foster even more success in Philadelphia.”

Hosting a new generation of top-tier, graduate-sized companies, BioLabs promises to deliver best-in-class, professionally managed laboratory space with expertise-driven operational support, consulting, and access to critical resources.

“We’re thrilled that BioLabs is joining us in housing cutting-edge life science companies at The Curtis,” said Keystone Founder and CEO, Bill Glazer. “With a full pipeline of flexible spaces enabling the company to grow at The Curtis, BioLabs will be able to expand their offerings and accelerate the long-term success of the companies they support.”

The Curtis, redeveloped by Keystone Properties, has become a fast-growing hub of top life science companies. Tenants include clinical-stage biotechnology firm Imvax, which extended its lease and more than doubled its footprint in the building with an expansion executed in April 2021; bio-pharma discovery startup Vivodyne, which joined the roster last year; and clinical stage biotechnology company Applied Genetic Technologies Corporation (AGTC) — which leased space on the eighth floor of the building due to its initial focus in ophthalmology, and which aligns well with its proximity to Wills Eye Hospital that is part of Thomas Jefferson University Hospitals, another tenant at The Curtis.

Finally, Chimeron Bio — an RNA company developing next-generation products for use in oncology and the treatment of rare infectious diseases — will also be joining the new BioLabs life science-focused Philadelphia coworking space.

“We are pleased to be a part of BioLabs, a leader in nurturing biotech innovation,” said co-founder and CEO of Chimeron Bio, Dr. Jolly Mazumdar, PhD, MBA. “A growth-company such as Chimeron Bio needs a facility that will offer unwavering support critical to its team’s success. We are confident that BioLabs Philadelphia, led by Dr. Melina Blees, is that place, and, together, we can bring high-impact, accessible RNA medicines to patients and be major players in Philly’s growing life science ecosystem.”

Comments are closed.